STAT : Brazil dismisses antitrust complaint against Gilead over pricing for a hepatitis C drug
In a victory for Gilead, Brazilian antitrust authorities dismissed a complaint alleging the company charged “abusive” prices for a hepatitis C treatment.
STAT : Brazil dismisses antitrust complaint against Gilead over pricing for a hepatitis C drug
In a victory for Gilead, Brazilian antitrust authorities dismissed a complaint alleging the company charged “abusive” prices for a hepatitis C treatment.